BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9178029)

  • 1. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S
    Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory profile of immunoreactive growth hormone-releasing hormone (IR-GHRH) during sleep in man and its clinical value.
    Saito H; Hosoi E; Saito S
    Horm Metab Res; 1997 Sep; 29(9):422-6. PubMed ID: 9370108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
    Rosskamp R; Schmid G; Klumpp J; Tegeler A
    Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
    Coiro V; Volpi R; Capretti L; Finardi L; Magotti MG; Manfredi G; Chiodera P; Saccani Jotti G
    Horm Res; 2004; 62(2):88-91. PubMed ID: 15249740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation.
    Saito H; Saito S; Sano T; Hosoi E; Saito H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):567-71. PubMed ID: 6130103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
    Donnadieu M; Evain-Brion D; Tonon MC; Vaudry H; Job JC
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1132-4. PubMed ID: 3923020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man.
    Masuda A; Shibasaki T; Kim YS; Imaki T; Hotta M; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1989 Oct; 69(4):906-9. PubMed ID: 2506217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
    Hanew K; Tanaka A; Utsumi A
    J Endocrinol Invest; 1998 Feb; 21(2):72-7. PubMed ID: 9585379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K; Utsumi A
    Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.
    Roelfsema F; Biermasz NR; Veldman RG; Veldhuis JD; Frölich M; Stokvis-Brantsma WH; Wit JM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2459-64. PubMed ID: 11397840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive growth hormone-releasing hormone in rat placenta.
    Meigan G; Sasaki A; Yoshinaga K
    Endocrinology; 1988 Aug; 123(2):1098-102. PubMed ID: 2899497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hormone in normal children.
    Tapanainen P; Rantala H; Leppäluoto J; Lautala P; Käär ML; Knip M
    Pediatr Res; 1989 Nov; 26(5):404-9. PubMed ID: 2510118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.